Neurovalens raised €6.9M in a funding round in Aug 2025. The company is based in Belfast, Ireland. Investors in the round: Angel Co-Fund, Innovation Ulster, Investment Fund for Northern Ireland (IFNI) and 2 others. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
